Shares of BG Medicine Inc. (OTCMKTS:BGMD – Get Free Report) crossed above its two hundred day moving average during trading on Thursday. The stock has a two hundred day moving average of $0.00 and traded as high as $0.0001. BG Medicine shares last traded at $0.00, with a volume of 0 shares.
BG Medicine Stock Performance
BG Medicine Company Profile
The company’s best-known product was the Galectin-3 test, a laboratory assay designed to measure galectin-3, a biomarker associated with cardiac fibrosis and the progression of heart failure. BG Medicine also developed other diagnostic products and research programs involving cardiovascular and metabolic disease biomarkers.
BG Medicine was headquartered in Waltham, Massachusetts, and its products were marketed through clinical laboratory and healthcare channels in the United States and select international markets.
Read More
- Five stocks we like better than BG Medicine
- 3 Unique ETFs With Strong Momentum for the End of the Year
- 3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Ahead
- Schneider Just Paid Up for PTC—Is the SaaSpocalypse Overdone?
- Delta Air Lines Faces a Fuel Crisis—But There’s a Silver Lining
Receive News & Ratings for BG Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BG Medicine and related companies with MarketBeat.com's FREE daily email newsletter.
